Alastair Garfield
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Alastair Garfield
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 24 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Alastair Garfield
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| IMMUNOGEN, INC. | Biotechnology | Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Sales & Marketing Chief Operating Officer | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Biotechnology | Founder Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Florida | College/University | Undergraduate Degree Graduate Degree | |
| TREVI THERAPEUTICS, INC. | Biotechnology | Founder Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of Leeds | College/University | Undergraduate Degree | |
Cancer Support Community
 Cancer Support Community Miscellaneous Commercial ServicesCommercial Services Cancer Support Community is an American company that provides support to people with cancer. The non-profit company is based in Washington. The company focuses on helping those who experience cancer cachexia, a syndrome that causes drastic weight and muscle loss in cancer patients. The company was founded in 1982 by Harold Benjamin. Debbie Weir has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
| College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree | |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Hospital/Nursing Management | Public Communications Contact | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Independent Print Ltd.
 Independent Print Ltd. Publishing: NewspapersConsumer Services Independent Print Ltd. operates as a newspaper publishing company. It prints and publishes newspapers. The company was founded was founded by Andreas Whittam Smith on February 5, 2010 and is headquartered in London, the United Kingdom. | Publishing: Newspapers | Director/Board Member | |
Teva Pharmaceuticals Ltd.
 Teva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals Ltd. manufactures pharmaceutical products. The company was incorporated on October 19, 1972 and is headquartered in Castleford, the United Kingdom. | Pharmaceuticals: Major | Human Resources Officer | |
| Kellogg School of Management | College/University | Masters Business Admin | |
| University of Manchester Institute of Science & Technology | College/University | Undergraduate Degree | |
| OVID THERAPEUTICS INC. | Pharmaceuticals: Major | Human Resources Officer | |
| University of Pennsylvania | College/University | Doctorate Degree | |
| Harvard College | College/University | Undergraduate Degree | |
| University of Amsterdam | College/University | Graduate Degree | |
Cardurion Pharmaceuticals LLC
 Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
| PRIME MEDICINE, INC. | Biotechnology | Chief Executive Officer | |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
| Columbia University College of Physicians & Surgeons | College/University | Corporate Officer/Principal | |
Abraxis Health, Inc.
 Abraxis Health, Inc. BiotechnologyHealth Technology Abraxis Health is establishing as a fully-integrated, next-generation, evidence-based, and personalized healthcare company. It plans to develop a proprietary model for the delivery of healthcare. Abraxis Health is designing and acquiring the necessary infrastructure and plans to acquire and internally develop the hardware and software modules to organize and integrate the data streams that form the foundation of an interactive database. The firm will develop, test, and validate diagnostics and drugs to target pre-selected patients based on molecular profiles that predict drug response to particular therapeutics. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Retrotope, Inc.
 Retrotope, Inc. Pharmaceuticals: MajorHealth Technology Retrotope, Inc. operates as clinical-stage pharmaceutical company that develops drugs to treat degenerative diseases. It offers drugs and therapies to treat Parkinson’s, Alzheimer’s, mitochondrial myopathies and retinopathies diseases. The company was founded by Charles R. Cantor, Robert J. Molinari, and Mikhail S. Shchepinov in 2006 and is headquartered in Los Altos, CA. | Pharmaceuticals: Major | Director/Board Member | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact | |
Neurotez, Inc.
 Neurotez, Inc. BiotechnologyHealth Technology Neurotez, Inc. opertaes as a corporation, which develops leptin product as a novel hormone replacement therapy for alzheimer’s disease. The company was founded by Nikolaos Tezapsidis in 2004 and is headquartered in Bridgewater, NJ. | Biotechnology | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 39 |
| Vereinigtes Königreich | 7 |
| Kanada | 2 |
| Niederlande | 2 |
Sektoral
| Health Technology | 26 |
| Consumer Services | 14 |
| Commercial Services | 5 |
| Finance | 3 |
| Health Services | 3 |
Operativ
| Corporate Officer/Principal | 66 |
| Director/Board Member | 57 |
| Chief Tech/Sci/R&D Officer | 22 |
| Independent Dir/Board Member | 19 |
| Undergraduate Degree | 18 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Neil Exter | 33 |
| Camille Bedrosian | 18 |
| Lynn Tetrault | 15 |
| Keith Gottesdiener | 13 |
| Bart Henderson | 12 |
| Leonardus H. T. van der Ploeg | 12 |
| Jennifer Good | 10 |
| Stuart Arbuckle | 10 |
| Murray Stewart | 9 |
| Hunter Smith | 9 |
| Fred Fiedorek | 8 |
| David Connolly | 7 |
| Simon D. Kelner | 7 |
| Jim Flaherty | 6 |
| Nithya Desikan | 5 |
- Börse
- Insiders
- Alastair Garfield
- Unternehmensverbindungen